UFF
JAZZ icon

USA Financial Formulas’s Jazz Pharmaceuticals JAZZ Stock Holding History

USA Financial Formulas’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
1,008
+876
+664% +$192K 0.04% 114
2026
Q1 		$25K Buy
+132
New +$23.1K ﹤0.01% 242
2025
Q2 		– Sell
-2,710
Closed -$336K – 308
2025
Q1 		$336K Buy
+2,710
New +$354K 0.06% 100
2022
Q3 		$300K Buy
+2,254
New +$343K 0.47% 44

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

USA Financial Formulas's JAZZ Position: Q2 2026 in Review

USA Financial Formulas increased its Jazz Pharmaceuticals (JAZZ) stake by 664% in Q2 2026, buying an estimated $192K and bringing the position to 1,008 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #114.

USA Financial Formulas first reported a position in JAZZ in Q3 2022 and has held it in 4 quarters since. The position peaked at $336K in Q1 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • USA Financial Formulas held 1,008 shares of Jazz Pharmaceuticals worth $243K as of Q2 2026.
  • USA Financial Formulas bought 876 Jazz Pharmaceuticals shares in Q2 2026, an estimated $192K.
  • Jazz Pharmaceuticals made up 0.04% of USA Financial Formulas's portfolio in Q2 2026, its #114 holding.
  • USA Financial Formulas first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 4 quarters since.
  • USA Financial Formulas's Jazz Pharmaceuticals position peaked at $336K in Q1 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.